Clinical trial NCT02498795: Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy
Official title: Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Tendinopathy
Keywords: Intratissue Percutaneous Electrolysis
Dry needling
Eccentric exercise
Patella
Lead sponsor: Universidad de Zaragoza
Sponsor class: OTHER
Collaborators: name: Universidad San Jorge
First posted: 2015-07-15
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The accomplishment of a treatment with Intratissue Percutaneous Electrolysis of additional form to the accomplishment of eccentric exercise's program in patients with chronic patellar tendinopathy is more effective than the accomplishment of an additional treatment with dry needling or eccentric exercise's program realized of isolated form.

Detailed description: Experimental study randomized with double blind, whose purpose is to compare three protocols in those who apply different protocols of physical therapy to themselves in three groups of intervention with patients with chronic patellar tendinopathy.

There take part in this study young women of both sexes, of Zaragoza and of different sports clubs of entity 18 and 40 years, that they realize of habitual form (minimum 3 times a week) a sport. All of them present chronic patellar tendinopathy.

Eligibility criteria: Inclusion Criteria:

* Age understood between 18 and 40 years.
* To practise any sport of habitual form.
* Patients diagnosed of chronic patellar tendinopathy with a minimum of 3 months of evolution and with stable symptomatology.
* Pain to the palpation of the tendon in the low pole of the knee and during the training or competition.
* Punctuation of the questionnaire VISA-P under 80.

Exclusion Criteria:

* Patient had an operation on the knee affected in the last 6 months.
* Infiltrations in the knee affected in the last 3 months.
* Patient who has received pharmacological treatment or physical therapy in the last 48 hours.
* Pathology with less than 3 months of evolution.
* To present bilateral chronic tendinopathy.
* Punctuation of the questionnaire major or equal Visa - p of 80.
* Inability to apply someone of the techniques of treatment or valuation for absolute or relative contraindication.

Primary outcomes:
measure: Change from baseline in functionality at 8 weeks as measured by Visa-p
timeFrame: 8 weeks
Secondary outcomes:
measure: Pain, as measured by Visual Analog Scale
timeFrame: 0, 8 and 20 weeks
measure: Quality of life by SF-36
timeFrame: 0, 8 and 20 weeks
measure: Thickness of the tendon, as measured by ultrasound scan
timeFrame: 0, 8 and 20 weeks
measure: Height of the jump
timeFrame: 0, 8 and 20 weeks
measure: Concentric force of the low members
timeFrame: 0, 8 and 20 weeks
measure: Speed of the jump
timeFrame: 0, 8 and 20 weeks
measure: Hypervascularity, as measured by ultrasound scan
timeFrame: 0, 8 and 20 weeks
measure: Functionality, as measured by Visa-p
timeFrame: 0 and 20 weeks
Other outcomes:
Locations:
city: Villanueva de Gállego
country: Spain
facility: Universidad San Jorge
state: Zaragoza
Study officials:
affiliation: Universidad de Zaragoza
name: Eva Gómez-Trullén, PhD
role: STUDY_DIRECTOR
affiliation: Universidad San Jorge
name: Pablo Herrero, PhD
role: STUDY_DIRECTOR
References:
citation: Lopez-Royo MP, Rios-Diaz J, Galan-Diaz RM, Herrero P, Gomez-Trullen EM. A Comparative Study of Treatment Interventions for Patellar Tendinopathy: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2021 May;102(5):967-975. doi: 10.1016/j.apmr.2021.01.073. Epub 2021 Feb 6.
citation: Lopez-Royo MP, Gomez-Trullen EM, Ortiz-Lucas M, Galan-Diaz RM, Bataller-Cervero AV, Al-Boloushi Z, Hamam-Alcober Y, Herrero P. Comparative study of treatment interventions for patellar tendinopathy: a protocol for a randomised controlled trial. BMJ Open. 2020 Feb 16;10(2):e034304. doi: 10.1136/bmjopen-2019-034304.